Anthony R Fehr Selected Research

Endoribonucleases

1/2022	MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells.
12/2021	MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells.
1/2017	In Situ Tagged nsp15 Reveals Interactions with Coronavirus Replication/Transcription Complex-Associated Proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony R Fehr Research Topics

Disease

20	Infections 01/2022 - 01/2010
11	Virus Diseases (Viral Diseases) 12/2022 - 05/2011
6	Coronavirus Infections 12/2020 - 01/2017
4	COVID-19 01/2022 - 10/2020
3	Severe Acute Respiratory Syndrome 01/2022 - 02/2016
2	Pneumonia (Pneumonitis) 01/2019 - 02/2016
2	Weight Loss (Weight Reduction) 01/2018 - 02/2015
1	Pathologic Processes 01/2020

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2010
5	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2021 - 02/2015
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
4	Virulence Factors (Pathogenicity Factors)IBA 12/2021 - 10/2020
3	VaccinesIBA 01/2022 - 04/2018
3	EndoribonucleasesIBA 01/2022 - 01/2017
3	Pharmaceutical PreparationsIBA 12/2021 - 01/2019
3	EnzymesIBA 12/2020 - 01/2020
3	CytokinesIBA 01/2020 - 02/2015
3	InterferonsIBA 01/2020 - 02/2015
3	Viral DNAIBA 08/2013 - 01/2010
2	Uridylate-Specific EndoribonucleasesIBA 01/2022 - 12/2021
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2022 - 12/2021
2	AsparagineIBA 12/2021 - 03/2021
2	nicotinamide-beta-ribosideIBA 12/2020 - 10/2020
2	Niacinamide (Nicotinamide)FDA LinkGeneric 12/2020 - 10/2020
2	NAD (NADH)IBA 12/2020 - 10/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2015
2	Biological ProductsIBA 01/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2017
2	Viral ProteinsIBA 01/2017 - 01/2010
1	ChromatinIBA 12/2022
1	Nucleic AcidsIBA 12/2022
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	2-5A-dependent ribonuclease (RNase L)IBA 01/2022
1	Ribose (D-Ribose)IBA 12/2021
1	ADP-ribosylarginine hydrolaseIBA 03/2021
1	Alanine (L-Alanine)FDA Link 03/2021
1	HydrolasesIBA 01/2021
1	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Attenuated VaccinesIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Blocking AntibodiesIBA 01/2018
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Karyopherins (Importin)IBA 01/2018
1	Adenosine Diphosphate (ADP)IBA 01/2018
1	DNA Primase (Primase)IBA 01/2017
1	ProstaglandinsIBA 01/2017
1	Prostaglandin D2IBA 01/2017
1	Interferon Type IIBA 02/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2015
1	ChemokinesIBA 02/2015
1	Glycoproteins (Glycoprotein)IBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2012

Therapy/Procedure

4	Therapeutics 01/2022 - 04/2018
1	Ligation 01/2020